Spark Therapeutics' Revolutionary Gene Therapy for Blindness Faces the FDA on Thursday Post author:Sam Post published:October 9, 2017 Post category:BioPharma October 10, 2017By Mark Terry… Source: BioSpace You Might Also Like 1-Year Old Biotech Goldfinch Steals AstraZeneca R&D Exec for CEO Post December 5, 2017 Amgen Leaps Into the World of Regenerative Medicine With New Investment November 7, 2017 This Drug Could be Johnson & Johnson's Next Billion-Dollar Blockbuster January 25, 2017
